Austar Lifesciences Limited
6118.HK
Get informed when a big investor buys or sells
+ FollowMarket Cap$358.81M
Close$
Share Statistics
| Market cap | $358.81 Million |
|---|---|
| Enterprise Value | $609.60 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $0.07 |
| Beta | 0.84 |
| Outstanding Shares | 512,582,000 |
Return
| Return on Equity | 6.30% |
|---|---|
| Return on Assets | 2.45% |
| Return on Invested Capital | 6.94% |
Valuation & Multiples
| P/E Ratio | 17.79 |
|---|---|
| PEG | -26.7 |
| Price to Sales | 0.13 |
| Price to Book Ratio | 0.67 |
| Enterprise Value to Revenue | 0.2 |
| Enterprise Value to EBIT | 9.33 |
| Enterprise Value to Net Income | 11 |
| Total Debt to Enterprise | 0.83 |
| Debt to Equity | 0.61 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Austar Lifesciences Limited
1,468 employees
CEO: Kwok Keung Austar Lifesciences Limited functions as an investment holding company, delivering integrated engineering and technology solutions to pharmaceutical production facilities and research institutions globally, with a significant presence in...